During the past decade, Jackson Arthritis Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jackson Arthritis Clinic" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jackson Arthritis Clinic" are "Rheumatoid Arthritis" (7 trials). Many other conditions were trialed in "Jackson Arthritis Clinic" in a lesser frequency.

Most popular intervention types in "Jackson Arthritis Clinic" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (4 trials), "Placebo" (3 trials), "Tocilizumab" (3 trials), "Ocrelizumab" (2 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jackson Arthritis Clinic" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Jackson Arthritis Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jackson Arthritis Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Jackson Arthritis Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".